Podcast Episodes
Back to Search
Medicus Pharma cleared to launch Phase 2b Teverelix study in Prostate Cancer
Episode 13935
Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive to announce that the company has received “study may proceed” clearance from t…
2 weeks, 6 days ago
Genflow CEO on promising dog longevity data, next steps
Episode 13933
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) CEO Dr Eric Leire talked with Proactive's Stephen Gunnion about preliminary interim results …
2 weeks, 6 days ago
Seeing Machines CEO on Q2 KPIs, royalties growth & GSR boost
Episode 13932
Seeing Machines Ltd (AIM:SEE, OTC:SEEMF) CEO Paul McGlone talked with Proactive's Stephen Gunnion about second-quarter KPIs, highlighting growth in a…
2 weeks, 6 days ago
Record Resources advances Ngulu Oil Block plans in Gabon
Episode 13930
Record Resources CEO Michael Judson joined Steve Darling from Proactive to discuss the company’s significant oil exploration and development strategy…
2 weeks, 6 days ago
Amerant CIO bullish on Latin America debt
Episode 13929
Amerant Investments chief investment officer Baylor Lancaster-Samuel talked with Proactive's Stephen Gunnion about shifting investor sentiment toward…
2 weeks, 6 days ago
Quadrise CEO Peter Borup on MSAR trials and 2026 priorities
Episode 13924
Quadrise PLC (AIM:QED) CEO Peter Borup joined Stephen Gunnion in the Proactive studio to discuss the company’s evolving strategy, market conditions a…
3 weeks ago
Standard Uranium launches maiden drill program at Corvo Project
Episode 13931
Standard Uranium CEO Jon Bey and Vice President of Exploration Sean Hillacre joined Steve Darling from Proactive on site at the company’s Corvo Proje…
3 weeks ago
Virtuix expands Omni One sales to Europe, launches across key EU markets
Episode 13923
Virtuix CEO Jan Goetgeluk joined Steve Darling from Proactive to announce the expansion of Omni One sales into Europe, marking a major milestone in t…
3 weeks ago
Arecor targets phase II insuling trial for 2026 after successful 2025
Episode 13928
Arecor Therapeutics PLC's (AIM:AREC) CEO Sarah Howell talked with Proactive's Stephen Gunnion about the company’s second-half performance and its str…
3 weeks ago
Genflow Biosciences CEO explains AGM RNS; says it's about negotiation from a position of power
Episode 13927
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) CEO Dr Eric Leire talked with Proactive's Stephen Gunnion about the company’s latest RNS reg…
3 weeks ago